28 April 2017
News and Views
Links and Services
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis, finds a study published in the latest issue of Gastroenterology.
Adalimumab is effective for induction and maintenance of remission in patients with moderate to s
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors